ArticleFrontiers in immunology2023

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes.

Milena Kalaitsidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.